Today’s Research Reports on Trending Tickers: Ironwood Pharmaceuticals and Global Blood Therapeutics
Wall Street closed up on Thursday as tech shares rallied and trade tensions eased on the hopes of a fresh round of trade talks that could potentially take place later this month. The Dow Jones Industrial Average climbed 0.57 percent to close at 26,145.99, while the S&P 500 Index jumped 0.53 percent to close at 2,904.18. The Nasdaq Composite Index gained 0.75 percent to close at 8,013.71.
“Markets today are moving primarily on China trade [and] tariff news,” according to Mark Esposito, chief executive of Esposito Securities in Dallas. “U.S. officials reaching out to China saying they would be amenable to additional trade talks later this month—that’s all it took to get and keep the Dow up triple digits,” Esposito added.
RDI Initiates Coverage on:
Ironwood Pharmaceuticals, Inc.
Global Blood Therapeutics, Inc.
Ironwood Pharmaceuticals’ stock jumped 4.96% Thursday, to close the day at $18.19. The stock recorded a trading volume of 1,268,156 shares, which was above its three months average volume of 997,581 shares. In the last year, Ironwood Pharmaceuticals’ shares have traded in a range of 12.89 – 21.20. The share price has gained 41.12% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $18.68 is above its 200-day moving average of $17.75. Shares of Ironwood Pharmaceuticals have fallen roughly 4.11 percent in the past month and are up 21.35 percent year-to-date.
Access RDI’s Ironwood Pharmaceuticals, Inc. Research Report at:
On Thursday, shares of Global Blood Therapeutics recorded a trading volume of 1,661,354 shares, which was above the three months average volume of 1,310,692 shares. The stock ended the day 7.4% lower at $42.55. The share price has fallen 37.47% from its 52 week high with a 52 week trading range of 26.10 – 68.05. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $46.74 is below its 200-day moving average of $47.02. Shares of Global Blood Therapeutics have fallen roughly 5.76 percent in the past month and are up 8.13 percent year-to-date.
Access RDI’s Global Blood Therapeutics, Inc. Research Report at:
Our Actionable Research on Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Global Blood Therapeutics, Inc. (NASDAQ:GBT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.